Ascend Wellness Holdings, Inc. (AAWH)
Ascend Wellness Holdings, Inc. operates within the cannabis industry, specializing in the cultivation, processing, and distribution of packaged marijuana products. Its extensive product portfolio encompasses a variety of cannabis forms, including dried flower, pre-rolled joints, concentrated extracts, vaporizable products, edibles, and other related consumer items. As of December 31, 2021, the company maintained a substantial retail presence, with 20 dispensaries in operation. Beyond its own network, Ascend Wellness Holdings additionally supplies its merchandise to other authorized cannabis retailers. Established in 2018, the firm's corporate headquarters are located in New York, New York.
Sector: Medicinal Chemicals & Botanical Products
Industry: Drug Manufacturers - Specialty & Generic
Ascend Wellness Holdings, Inc.
| Form | Description | Links | |
|---|---|---|---|
| 10-Q | |||
| 8-K | |||
| 8-K | |||
| 10-Q | |||
| 8-K | |||
| DEFA14A | |||
| DEFA14A | |||
| DEF 14A | |||
| PRE 14A | |||
| 8-K | |||
| PREM14A | |||
| 10-Q | |||
| 8-K | |||
| 8-K | |||
| ARS | |||
| DEFA14A | |||
| DEF 14A | |||
| 10-K | |||
| 8-K | |||
| 8-K | |||
| 8-K | |||
| 8-K | |||
| EFFECT | |||
| CORRESP | |||
| UPLOAD |
1-25 of 149 filings
Recent SEC filings with analysis
- 10-QAscend Wellness Holdings filed its Q3 2026 10-Q showing net revenue of $130.0 million, up 4.2% year over year, with gross profit rising to $53.1 million and a…
- 8-KAWH reported Q3 2026 net revenue of $130.0 million, up 4.2% year-over-year and 3.1% sequentially, with Adjusted EBITDA of $31.1 million at a 23.9% margin.